Variability in engraftment potential of different peripheral blood stem cell preparations given after cyclophosphamide, thiotepa, and carboplatin for stage II/III breast cancer.

被引:0
|
作者
Elfenbein, G [1 ]
Perkins, J [1 ]
Janssen, W [1 ]
Fields, K [1 ]
机构
[1] H LEE MOFFITT CANC CTR,DIV BONE MARROW TRANSPLANTAT,TAMPA,FL
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:107 / 107
页数:1
相关论文
共 48 条
  • [1] Cyclophosphamide/thiotepa/mitoxantrone with autologous stem cell rescue for high risk stage II and stage III breast cancer
    Krüger, WH
    Kröger, N
    Königmann, M
    Berdel, WE
    Fuss, H
    Schultze, W
    Gieseking, F
    Schäfer-Eckart, K
    Möbus, V
    Frickhofen, N
    Wandt, H
    Illiger, HJ
    Metzner, B
    Kolbe, K
    Wörmann, B
    Trümper, L
    Huber, C
    Maass, H
    Jonat, W
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1998, 22 : S18 - S20
  • [2] No evidence of ototoxicity after high-dose chemotherapy with cyclophosphamide, carboplatin and thiotepa followed by stem cell transplantation in patients with breast cancer.
    Garner, G
    Harkness, K
    Britt, G
    Jillella, A
    BLOOD, 1998, 92 (10) : 274A - 274A
  • [3] Efficacy of high-dose paclitaxel in combination with cyclophosphamide, thiotepa, carboplatin and stem cell rescue for metastatic breast cancer.: A phase II trial.
    Mayordomo, JL
    Isla, D
    Yubero, A
    Cajal, R
    Martí, JL
    Herráez, J
    Bueso, P
    Murillo, L
    Sáenz, A
    Escudero, P
    Iñíguez, C
    Larrodé, P
    García-Prats, MD
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S52 - S52
  • [4] Addition of docetaxel to the cyclophosphamide/thiotepa/carboplatin regimen for autologous stem cell transplantation: A dose-escalation study of docetaxel for breast cancer.
    Kato, K
    Ohno, Y
    Miyoshi, T
    Mitsuyama, S
    Ohkubo, H
    BLOOD, 1998, 92 (10) : 367B - 367B
  • [5] Ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
    Jillella, AP
    Britt, GW
    Litaker, MS
    Kallab, AM
    Harkness, K
    Garner, GD
    MEDICAL ONCOLOGY, 2000, 17 (04) : 287 - 292
  • [6] ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
    AP Jillella
    GW Britt
    MS Litaker
    AM Kallab
    K Harkness
    GD Garner
    Medical Oncology, 2000, 17 : 287 - 292
  • [7] Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients
    Gori, S
    Mosconi, AM
    Tabilio, A
    Falzetti, F
    Aristei, C
    Basurto, C
    Cherubini, R
    Latini, P
    Martelli, MF
    Tonato, M
    Colozza, M
    TUMORI, 2001, 87 (03) : 138 - 141
  • [8] HIGH-DOSE CARBOPLATIN, THIOTEPA AND CYCLOPHOSPHAMIDE (CTC) WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN THE ADJUVANT THERAPY OF HIGH-RISK BREAST-CANCER - A PRACTICAL APPROACH
    VANDERWALL, E
    NOOIJEN, WJ
    BAARS, JW
    HOLTKAMP, MJ
    SCHORNAGEL, JH
    RICHEL, DJ
    RUTGERS, EJT
    SLAPERCORTENBACH, ICM
    VANDERSCHOOT, CE
    RODENHUIS, S
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 857 - 862
  • [9] Results of a prospective study with high-dose etoposide, thiotepa, carboplatin and peripheral blood stem cell (PBSC) rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients (pts).
    Gori, S
    Mosconi, AM
    Basurto, C
    Cherubini, R
    Aristei, C
    Tabilio, A
    Falsetti, F
    De Angelis, V
    Tonato, M
    Colozza, M
    ANNALS OF ONCOLOGY, 2000, 11 : 21 - 21
  • [10] Thiotepa, mitoxantrone and carboplatin (TMJ) and autologous hematopoietic stem cell transplantation in patients with stage II and IIIa breast cancer: An analysis of 116 patients.
    Kancherla, RR
    Ahmed, T
    Qureshi, Z
    Lo, S
    Mittelman, A
    Chun, H
    Puccio, C
    Seiter, K
    BLOOD, 2000, 96 (11) : 424A - 424A